Prokidney (PROK) Other Non-Current Liabilities (2022 - 2026)
Prokidney's (PROK) quarterly Other Non-Current Liabilities came in at $1.1 million in Q1 2026, up 40.58% year-on-year from $764000.0 in Q1 2025, and little changed on a QoQ basis from $1.1 million in Q4 2025.
Prokidney (PROK) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends
Prokidney (PROK) has 5 years of Other Non-Current Liabilities data on file, last reported at $1.1 million in Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 40.58% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $1.1 million, a 40.58% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, up 43.58% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $1.1 million, roughly flat from $1.1 million in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for PROK reached as high as $1.1 million in Q4 2025 and fell as low as $278000.0 in Q4 2022.
- Historically, Other Non-Current Liabilities has averaged $668666.7 across 5 years, with a median of $568000.0 in 2023.
- Across the five-year window, Other Non-Current Liabilities jumped 104.32% in 2023 and increased 14.98% in 2024, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $278000.0 in 2022, then surged by 104.32% to $568000.0 in 2023, then jumped by 31.69% to $748000.0 in 2024, then soared by 43.58% to $1.1 million in 2025, then changed by 0.0% to $1.1 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $962000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Prokidney | 96.00 Mn | 96.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.07 Mn |
| Dec 31, 2025 | 1.07 Mn |
| Sep 30, 2025 | 962,000.00 |
| Jun 30, 2025 | 903,000.00 |
| Mar 31, 2025 | 764,000.00 |
| Dec 31, 2024 | 748,000.00 |
| Sep 30, 2024 | 772,000.00 |
| Jun 30, 2024 | 568,000.00 |
| Mar 31, 2024 | 568,000.00 |
| Dec 31, 2023 | 568,000.00 |
| Sep 30, 2023 | 522,000.00 |
| Jun 30, 2023 | 494,000.00 |
| Mar 31, 2023 | 426,000.00 |
| Dec 31, 2022 | 278,000.00 |
| Sep 30, 2022 | 309,000.00 |